Kenvue /$KVUE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Kenvue
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
Ticker
$KVUE
Sector
Primary listing
NYSE
Employees
21,890
Headquarters
Website
Kenvue Metrics
BasicAdvanced
$34bn
21.26
$0.84
0.50
$0.83
4.65%
Price and volume
Market cap
$34bn
Beta
0.5
52-week high
$22.87
52-week low
$14.02
Average daily volume
21m
Dividend rate
$0.83
Financial strength
Current ratio
0.983
Quick ratio
0.607
Long term debt to equity
67.6
Total debt to equity
82.975
Dividend payout ratio (TTM)
97.84%
Interest coverage (TTM)
7.00%
Profitability
EBITDA (TTM)
3,470
Gross margin (TTM)
58.60%
Net profit margin (TTM)
10.61%
Operating margin (TTM)
19.65%
Effective tax rate (TTM)
26.71%
Revenue per employee (TTM)
$700,000
Management effectiveness
Return on assets (TTM)
6.97%
Return on equity (TTM)
15.70%
Valuation
Price to earnings (TTM)
21.262
Price to revenue (TTM)
2.24
Price to book
3.23
Price to tangible book (TTM)
-4.69
Price to free cash flow (TTM)
18.791
Free cash flow yield (TTM)
5.32%
Free cash flow per share (TTM)
0.95
Dividend yield (TTM)
4.65%
Forward dividend yield
4.65%
Growth
Revenue change (TTM)
-0.07%
Earnings per share change (TTM)
52.31%
3-year revenue growth (CAGR)
0.17%
3-year earnings per share growth (CAGR)
-10.26%
What the Analysts think about Kenvue
Analyst ratings (Buy, Hold, Sell) for Kenvue stock.
Kenvue Financial Performance
Revenues and expenses
Kenvue Earnings Performance
Company profitability
Kenvue News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs